PHS.F 5.26 (+5.62%)
NO0010000045Drug ManufacturersDrug Manufacturers - Specialty & Generic

PhotoCure (PHS.F) Stock Highlights

5.26 | +5.62%
2024-12-21 06:41:02
PhotoCure ASA is a Norway-based specialty pharmaceutical company. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. The operating segments of the group are the Commercial franchise and Development portfolio. The company markets product through its commercial operation in the Nordic region under the brand name Hexvix and in the US under the brand name Cysview. It generates prime revenue from the Commercial franchise segment, which includes the Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, United Kingdom, Netherlands, Other European countries, and United States.

Statistics

Range Today
5.11 5.26
Volume Today 20
Range 1 Year
4.01 6.13
Volume 1 Year 384
Range 3 Year
3.44 12.57
Volume 3 Year 3.39K
Range 10 Year
3.41 14.79
Volume 10 Year 71.78K

Highlights

Market Capitalization 131.6M (small)
Floating Shares 22.2M
Current Price 5.26
Price To Earnings 112.5
Price To Revenue -0.25
Price To Book 0.24
Earnings Per Share 0.04
Payout Ratio 0%

Performance

Latest +5.62%
1 Month +21.48%
3 Months +20.92%
6 Months -4.19%
1 Year -6.9%
3 Years -43.01%
5 Years +20.92%
10 Years -11.45%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.